abstract |
This invention provides novel decahydroisoquinoline compounds of the formula (See formula I) which are useful as excitatory amino acid receptor antagonists and in the treatment of neuroglogical disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof. |